The study assessing molecular characteristics of lung adenocarcinomas, which harbor EGFR, KRAS mutations or ALK rearrangements as well as triple negative adenocarcinomas, dominated the top 10 alignment outcomes [59]. Here, ALK is linked to lung adenocarcinoma.